Gaucher cells md pathology exam question robbins based answer

Reading File
Finding Sources
Searching PubMed

"Gaucher Disease"[MeSH Terms]

Searching the Web

Gaucher disease pathology Gaucher cells glucocerebrosidase authoritative pathology

Reading File
Reading File
Reading File

Gaucher cells

Definition:
Gaucher cells are large, lipid-laden macrophages seen characteristically in Gaucher disease, an autosomal recessive lysosomal storage disorder caused by deficiency of β-glucocerebrosidase.

Pathogenesis

  • Mutation in the GBA gene causes deficient glucocerebrosidase activity.
  • Normally, this enzyme removes glucose from ceramide.
  • Deficiency causes accumulation of glucocerebroside (glucosylceramide) within lysosomes, mainly in macrophages of the mononuclear phagocyte system.
  • The enlarged, storage-laden macrophages are called Gaucher cells.

Morphology of Gaucher cells

  • Large, plump macrophages, often up to 100 μm in diameter.
  • One or more small, dark, eccentrically placed nuclei.
  • Cytoplasm is abundant, pale, and finely fibrillary with the classic “crumpled tissue paper” appearance.
  • Unlike Niemann-Pick cells, Gaucher cells are not typically foamy or vacuolated.
  • PAS stain: strongly positive.
  • Electron microscopy: elongated, distended lysosomes containing stored lipid arranged in stacks of bilayers.

Sites where found

Gaucher cells occur especially in:
  • Bone marrow - an important diagnostic site
  • Spleen
  • Liver
  • Lymph nodes
  • Tonsils
  • Thymus
  • Peyer patches
  • Lungs, including alveolar septa and air spaces

Clinical significance

Accumulation in marrow and reticuloendothelial organs causes:
  • Massive splenomegaly and hepatomegaly
  • Cytopenias, especially thrombocytopenia and anemia, due to hypersplenism and marrow infiltration
  • Bone pain, osteopenia, bone infarction, erosions, and pathological fractures
Macrophage activation and cytokine release, including IL-1, IL-6, and TNF, also contribute to bone destruction and systemic disease.

Important differential: Gaucher vs Niemann-Pick cells

FeatureGaucher cellNiemann-Pick cell
Stored lipidGlucocerebrosideSphingomyelin
CytoplasmWrinkled, fibrillary, “crumpled tissue paper”Foamy, vacuolated
Enzyme defectβ-glucocerebrosidaseSphingomyelinase in types A/B
PAS stainStrongly positiveNot the classic defining feature
EMTubular/elongated lysosomes with bilayer stacksLamellated myelin figures or zebra bodies
Exam one-liner:
Gaucher cells are enlarged PAS-positive macrophages with eccentric nuclei and fibrillary “crumpled tissue paper” cytoplasm due to lysosomal accumulation of glucocerebroside in β-glucocerebrosidase deficiency.
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 154-155.

Brief about gaucher disease

Reading File
Finding Sources
Searching PubMed

"Gaucher Disease"[MeSH Terms]

Searching the Web

Gaucher disease overview diagnosis treatment NIH GARD

Gaucher disease - brief note

Gaucher disease is the most common autosomal recessive lysosomal storage disorder.

Defect

  • Mutation in GBA gene
  • Deficiency of β-glucocerebrosidase
  • Causes accumulation of glucocerebroside (glucosylceramide) in macrophage lysosomes.

Pathology

Lipid-laden macrophages, called Gaucher cells, accumulate in:
  • Spleen
  • Liver
  • Bone marrow
  • Lymph nodes and lungs
Gaucher cells: large macrophages with eccentric nuclei and abundant fibrillary cytoplasm resembling “crumpled tissue paper.” They are strongly PAS-positive.

Clinical features

  • Massive splenomegaly ± hepatomegaly
  • Anemia and thrombocytopenia due to hypersplenism/marrow infiltration
  • Bone pain, osteopenia, infarcts, bone erosion, pathological fractures
  • Cytokine release by activated macrophages contributes to bone damage.

Types

  1. Type I: Chronic non-neuronopathic
    • Most common
    • No CNS involvement
    • Splenic and skeletal disease predominate.
  2. Type II: Acute neuronopathic
    • Infancy
    • Severe progressive CNS disease
    • Early death.
  3. Type III: Chronic neuronopathic
    • Systemic disease with gradually progressive neurologic involvement, often beginning in adolescence or early adulthood.

Diagnosis and treatment

  • Diagnosis: reduced glucocerebrosidase activity and GBA mutation analysis.
  • Treatment: enzyme replacement therapy and, in selected patients, substrate-reduction therapy.
One-line answer:
Gaucher disease is an AR lysosomal storage disorder due to β-glucocerebrosidase deficiency, causing glucocerebroside accumulation in macrophages and formation of PAS-positive Gaucher cells with “crumpled tissue paper” cytoplasm.
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 154-155.
This is a shared conversation. Sign in to Orris to start your own chat.